Brazil Osteoporosis Drugs Market 2016 Industry Trends, Survey, Growth and Forecast

Brazil Osteoporosis Drugs Market 2015 Industry Trends, Survey, Growth and Forecast 1

1 Osteoporosis Drugs Overview 1

1.1 Product Overview and Scope of Osteoporosis Drugs 1

1.2 Classification of Osteoporosis Drugs 2

1.2.1 Antiresorptive Drugs 3

1.2.2 Anabolic Drugs 4

1.3 Applications of Osteoporosis Drugs 4

1.4 Brazil Market Size Sales (Volume) and Revenue (Value) of Osteoporosis Drugs (2011-2021) 5

1.4.1 Brazil Osteoporosis Drugs Sales and Growth Rate (2011-2021) 5

1.4.2 Brazil Osteoporosis Drugs Revenue and Growth Rate (2011-2021) 6

2 Brazil Osteoporosis Drugs Competition by Manufacturers 7

2.1 Brazil Osteoporosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016) 7

2.2 Brazil Osteoporosis Drugs Revenue and Share by Manufacturers (2015 and 2016) 9

2.3 Brazil Osteoporosis Drugs Average Price by Manufacturers (2015 and 2016) 11

2.4 Osteoporosis Drugs Market Competitive Situation and Trends 12

2.4.1 Osteoporosis Drugs Market Concentration Rate 12

2.4.2 Osteoporosis Drugs Market Share of Top 3 and Top 5 Manufacturers 13

2.4.3 Mergers & Acquisitions, Expansion 14

3 Brazil Osteoporosis Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016) 16

3.1 Brazil Osteoporosis Drugs Sales and Market Share by Type (2011-2016) 16

3.2 Brazil Osteoporosis Drugs Revenue and Market Share by Type (2011-2016) 17

3.3 Brazil Osteoporosis Drugs Price by Type (2011-2016) 18

3.4 Brazil Osteoporosis Drugs Sales Growth Rate by Type (2011-2016) 19

4 Brazil Osteoporosis Drugs Sales (Volume) by Application (2011-2016) 20

4.1 Brazil Osteoporosis Drugs Sales and Market Share by Applications (2011-2016) 20

4.2 Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016) 21

4.3 Market Drivers and Opportunities 22

5 Brazil Osteoporosis Drugs Manufacturers ProfilesAnalysis 25

5.1 Eli Lilly 25

5.1.1 Company Basic Information, Manufacturing Base and Competitors 25

5.1.2 Osteoporosis Drugs Product Information 26

5.1.3 Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 27

5.1.4 Main BusinessBusiness Overview 28

5.2Novartis 29

5.2.1 Company Basic Information, Manufacturing Base and Competitors 29

5.2.2 Osteoporosis Drugs Product Information 30

5.2.3 Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 30

5.2.4 Main BusinessBusiness Overview 31

5.3 Pfizer 32

5.3.1 Company Basic Information, Manufacturing Base and Competitors 32

5.3.2 Osteoporosis Drugs Product Information 33

5.3.3 Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 34

5.3.4 Main BusinessBusiness Overview 35

5.4 Amgen 35

5.4.1 Company Basic Information, Manufacturing Base and Competitors 35

5.4.2 Osteoporosis Drugs Product Information 37

5.4.3 Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 37

5.4.4 Main BusinessBusiness Overview 38

5.5 Merck 39

5.5.1 Company Basic Information, Manufacturing Base and Competitors 39

5.5.2 Osteoporosis Drugs Product Types, Application and Specification 40

5.5.3 Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 40

5.5.4 Main BusinessBusiness Overview 41

5.6 Novo nordisk 42

5.6.1 Company Basic Information, Manufacturing Base and Competitors 42

5.6.2 Osteoporosis Drugs Product Information 43

5.6.3 Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 43

5.6.4 Main BusinessBusiness Overview 44

5.7 Actavis 45

5.7.1 Company Basic Information, Manufacturing Base and Competitors 45

5.7.2 Osteoporosis Drugs Product Introduction 46

5.7.3 Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 47

5.7.4 Main BusinessBusiness Overview 47

5.8 Roche 48

5.8.1 Company Basic Information, Manufacturing Base and Competitors 48

5.8.2 Osteoporosis Drugs Product Introduction 49

5.8.3 Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 49

5.8.4 Main BusinessBusiness Overview 51

6 Osteoporosis Drugs Manufacturing Cost Analysis 52

6.1 Osteoporosis Drugs Key Raw Materials Analysis 52

6.1.1 Key Suppliers of Raw Materials 52

6.1.2 Market Concentration Rate of Raw Materials 53

6.2 Proportion of Manufacturing Cost Structure 53

6.3 Manufacturing Process Analysis of Osteoporosis Drugs 54

7 Industrial Chain, Sourcing Strategy and Downstream Buyers 55

7.1 Osteoporosis Drugs Industrial Chain Analysis 55

7.2 Upstream Raw Materials Sourcing 55

7.3 Downstream Buyers 56

8 Marketing Strategy Analysis, DistributorsTraders 57

8.1 Marketing Channel 57

8.1.1 Direct Marketing 58

8.1.2 Indirect Marketing 58

8.1.3 Marketing Channel Development Trend 59

8.2 Market Positioning 60

8.2.1 Pricing Strategy 60

8.2.2 Brand Strategy 61

8.2.3 Target Client 61

8.3 DistributorsTraders List 62

9 Market Effect Factors Analysis 63

9.1 Technology ProgressRisk 63

9.1.1 Substitutes Threat 63

9.1.2 Technology Progress in Related Industry 63

9.2 Consumer NeedsCustomer Preference Change 64

9.3 EconomicPolitical Environmental Change 64

10 Brazil Osteoporosis Drugs Market Forecast (2016-2021) 65

10.1 Brazil Osteoporosis Drugs Sales, Revenue Forecast (2016-2021) 65

10.2 Brazil Osteoporosis Drugs Sales Forecast by Type (2016-2021) 66

10.3 Brazil Osteoporosis Drugs Sales Forecast by Application (2016-2021) 66

10.4 Osteoporosis Drugs Price Forecast (2016-2021) 67

11 Research Findings and Conclusion 68

12 Appendix 69

Author List 69

Disclosure Section 70

Research Methodology 70

Data Source 71

Disclaimer 71

Figure Picture of Osteoporosis Drugs (Fosamax) 2

Table Classification of Osteoporosis Drugs 2

Figure Brazil Sales Market Share of Osteoporosis Drugs by Types in 2015 3

Figure Antiresorptive Drugs Picture 3

Figure Anabolic Drugs Picture 4

Figure Brazil Sales Market Share of Osteoporosis Drugs by Applications in 2015 4

Figure Brazil Osteoporosis Drugs Sales (K Unit) and Growth Rate (2011-2021) 5

Figure Brazil Osteoporosis Drugs Revenue (M USD) and Growth Rate (2011-2021) 6

Table Brazil Osteoporosis Drugs Sales (K Unit) of Key Manufacturers (2015 and 2016) 7

Table Brazil Osteoporosis Drugs Sales Share by Manufacturers (2015 and 2016) 7

Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers 8

Figure 2016 Osteoporosis Drugs Sales Share by Manufacturers 8

Table Brazil Osteoporosis Drugs Revenue (M USD) by Manufacturers (2015 and 2016) 9

Table Brazil Osteoporosis Drugs Revenue Share by Manufacturers (2015 and 2016) 9

Table 2015 Brazil Osteoporosis Drugs Revenue Share by Manufacturers 10

Table 2016 Brazil Osteoporosis Drugs Revenue Share by Manufacturers 10

Table Brazil Market Osteoporosis Drugs Average Price (USDUnit) of Key Manufacturers (2015 and 2016) 11

Figure Brazil Market Osteoporosis Drugs Average Price (USDUnit) of Key Manufacturers in 2015 12

Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers 13

Table Osteoporosis Drugs Market Share of Top 3 Manufacturers in 2015 13

Table Osteoporosis Drugs Market Share of Top 5 Manufacturers in 2015 13

Table Osteoporosis Drugs Market Mergers & Acquisitions, Expansion 14

Table Brazil Osteoporosis Drugs Sales (K Unit) by Type (2011-2016) 16

Table Brazil Osteoporosis Drugs Sales Share by Type (2011-2016) 16

Figure Brazil Osteoporosis Drugs Sales Market Share by Type in 2015 17

Table Brazil Osteoporosis Drugs Revenue (M USD) and Market Share by Type (2011-2016) 17

Table Brazil Osteoporosis Drugs Revenue Share by Type (2011-2016) 17

Figure Revenue Market Share of Osteoporosis Drugs by Type (2011-2016) 18

Table Brazil Osteoporosis Drugs Price (USDUnit) by Types (2011-2016) 18

Figure Brazil Osteoporosis Drugs Sales Growth Rate by Type (2011-2016) 19

Table Brazil Osteoporosis Drugs Sales (K Unit) by Applications (2011-2016) 20

Table Brazil Osteoporosis Drugs Sales Market Share by Applications (2011-2016) 20

Figure Brazil Osteoporosis Drugs Sales Market Share by Applications in 2015 21

Table Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016) 21

Figure Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016) 22

Table Prevalence of Osteoporosis Based on Different Studies in the Brazilian Population 23

Table Costs in USD of Diagnostic Tests for Osteoporosis 24

Table Low Bone Density Prevalence According to Brazilian Studies 24

Table Eli Lilly Basic Information List 25

Figure Osteoporosis Drugs Product Introduction of Eli Lilly 26

Table Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 27

Figure Eli Lilly Osteoporosis Drugs Revenue Market Share (2015 and 2016) 27

Figure Main BusinessBusiness of Eli Lilly 28

Table Novartis Basic Information List 29

Figure Osteoporosis Drugs Product Picture of Novartis 30

Table Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 30

Figure Novartis Osteoporosis Drugs Revenue Market Share (2015 and 2016) 31

Table Pfizer Basic Information List 32

Figure Osteoporosis Drugs Product Introduction of Pfizer 33

Table Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 34

Figure Pfizer Osteoporosis Drugs Revenue Market Share (2015 and 2016) 34

Figure Main BusinessBusiness Overview of Pfizer 35

Table Amgen Basic Information List 35

Figure Osteoporosis Drugs Product Introduction of Amgen 37

Table Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 37

Figure Amgen Osteoporosis Drugs Revenue Market Share (2015 and 2016) 38

Table Main BusinessBusiness Overview 38

Table Merck Basic Information List 39

Figure Osteoporosis Drugs Product Picture of Merck 40

Table Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 40

Figure Merck Osteoporosis Drugs Revenue Market Share (2015 and 2016) 41

Table Novo nordisk Basic Information List 42

Figure Osteoporosis Drugs Product Picture of Novo nordisk 43

Table Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 43

Figure Novo nordisk Osteoporosis Drugs Revenue Market Share (2015 and 2016) 44

Figure Main BusinessBusiness Overview 44

Table Actavis Basic Information List 45

Table Osteoporosis Drugs Product Introduction 46

Table Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 47

Figure Actavis Osteoporosis Drugs Revenue Market Share (2015 and 2016) 47

Table Roche Basic Information List 48

Table Osteoporosis Drugs Product Introduction 49

Table Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016) 49

Figure Roche Osteoporosis Drugs Revenue Market Share (2015 and 2016) 50

Figure Roche Main BusinessBusiness Overview 51

Table Key Suppliers of Raw Material 52

Figure Market Concentration Rate of Global Active Pharmaceutical Ingredient (API) Market in 2015 53

Figure Manufacturing Cost Structure of Osteoporosis Drugs in 2015 53

Figure General Manufacturing Process Analysis of Osteoporosis Drugs 54

Figure Osteoporosis Drugs Industrial Chain Analysis 55

Table Major Buyers of Osteoporosis Drugs 56

Figure Marketing Channels of Osteoporosis Drugs 57

Figure Direct Sales Proportion of Osteoporosis Drugs (2011-2015) 58

Figure Indirect Sales Proportion of Osteoporosis Drugs (2011-2015) 58

Figure Direct & Indirect Sales Proportion Forecast of Osteoporosis Drugs (2016-2021) 59

Figure Brazil Osteoporosis Drugs Price by Companies in 2015 (USDUnit) 60

Figure Brazil Osteoporosis Drugs Price by Product Types in 2015 (USDUnit) 60

Figure Brazil Major Brands Market Share of Osteoporosis Drugs in 2015 (Revenue) 61

Table Target Client in Brazil 61

Table DistributorsTraders List 62

Figure Customer Purchase Channels Preference of Osteoporosis Drugs in 2015 64

Figure Brazil Osteoporosis Drugs Sales (K Unit) and Growth Rate Forecast (2016-2021) 65

Figure Brazil Osteoporosis Drugs Revenue (M USD) and Growth Rate Forecast (2016-2021) 66

Table Brazil Osteoporosis Drugs Sales (K Unit) Forecast by Type (2016-2021) 66

Table Brazil Osteoporosis Drugs Sales (K Unit) Forecast by Application (2016-2021) 66

Table Brazil Osteoporosis Drugs Price (USDUnit) Forecast (2016-2021) 67